Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

Published On 2019-01-01 05:33 GMT   |   Update On 2019-01-01 05:33 GMT

The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of 'non-executive non-independent director' with immediate effect, Fortis Healthcare said in a filing to the BSE.


New Delhi: Fortis Healthcare Monday said it has appointed Shirish Moreshwar Apte as vice-chairman of the company. It has also extended the last date for the acquisition of a portfolio of assets of the Singapore-listed entity RHT Health Trust to March 26, 2019.

The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of 'non-executive non-independent director' with immediate effect, Fortis Healthcare said in a filing to the BSE.

"He will hold the office up to the ensuing annual general meeting and will be regularised, subject to the approval of the shareholders," it added.

Apte was appointed to the board of IHH Healthcare Berhad in September 2014, Fortis Healthcare said.

Currently, he is also the independent non-executive chairman of Pierfront Mezzanine Fund Pte. Apte concurrently serves on several boards of directors including Commonwealth Bank of Australia, the Supervisory Board of Bank Handlowy, Poland and Fullerton India Credit Company Ltd, it added.

Prior to his retirement from Citigroup in 2014 as chairman of Asia Pacific Banking, Apte had built up a 32-year career with Citibank/Citigroup, Fortis Healthcare said.

The board of directors has also approved the appointment of BSR & Co LLP as the statutory auditors of the company with immediate effect, as its earlier auditors Deloitte Haskins & Sells LLP resigned with effect from December 28, 2018.

BSR & Co LLP will hold the office till the conclusion of the ensuing annual general meeting subject to the approval of shareholders of the company, Fortis Healthcare said in a filing to the BSE.

The board of directors have also "approved the extension of the long stop date of December 31, 2018, under the Master Purchase Agreement (MPA) to March 26, 2019, as per mutual agreement, and on the same terms and conditions undertaken for the earlier extension vide amendment agreement dated August 24, 2018. The extension of the long stop date has been accepted and approved by RHT as well," it added.


Read Also: Fortis Healthcare, Fortis Hospitals to recover Rs 403 crore from Singh brothers and 7 others: SEBI

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News